Modulation of the effect of anthracycline efficacy and toxicity by ICRF-187.
Blum
R H
RH
Division of Medical Oncology, Kaplan Cancer Center, New York University Medical Center, New York 10016.
Walsh
C
C
Green
M D
MD
Speyer
J L
JL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004357:Drug Synergism; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D011929:Razoxane / Q000008:administration & dosage*
D010879:Piperazines; D011929:Razoxane; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil